NASDAQ: GLUE · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Monte Rosa Therapeutics Inc.

How Monte Rosa Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$924.8M

Price

$10.84

P/E

-5.7

EPS (TTM)

$-1.89

1-year return

15.9%

Dividend yield

0.0%

52-week range

$9.74–$13.52

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources